Postdoctoral Fellow
Blavatnik Center for Drug Discovery, Tel-Aviv University, Israel
Dr. Ohad Meir graduated from the Faculty of Biotechnology and Food Engineering at the Technion - Israel Institute of Technology, where he was mentored by Prof. Amram Mor, with whom he studied de-novo design and development of antimicrobial peptide mimics. He completed his M.Sc. summa cum laude in 2017, and his Ph.D. in 2022. During that period, he mastered techniques pertaining to peptide chemistry as well as to their assessment in-vitro and in-vivo using various murine models. In his publications, he contributed to establish the notion that non-antibiotic lipopeptide-like agents can generate superficial transient membrane damages that can nevertheless be harnessed for potentiation of ineffective antimicrobials.
Dr. Meir joined the Blavatnik Center for Drug Discovery (BCDD) high-throughput screening (HTS) unit as a research fellow in 2023, where he leads various high throughput screening projects. These are accomplished through utilization of cellular- as well as enzymatic-based platforms, respectively assessing phenotypic and mechanistic effects of tested compound libraries.